RhumbLine Advisers
AFIB

RhumbLine Advisers’s Acutus Medical Inc AFIB Stock Holding History

RhumbLine Advisers’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,238
Closed -$17K – 3277
2022
Q1 		$17K Buy
12,238
+1,048
+9% +$2.24K ﹤0.01% 3003
2021
Q4 		$38K Buy
11,190
+100
+0.9% +$563 ﹤0.01% 2991
2021
Q3 		$98K Buy
11,090
+725
+7% +$9.54K ﹤0.01% 2997
2021
Q2 		$176K Buy
+10,365
New +$152K ﹤0.01% 2931
2021
Q1 		– Sell
-9,806
Closed -$283K – 3035
2020
Q4 		$283K Buy
9,806
+1,592
+19% +$43.1K ﹤0.01% 2697
2020
Q3 		$245K Buy
+8,214
New +$249K ﹤0.01% 2607

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RhumbLine Advisers's AFIB Position: Q2 2022 in Review

RhumbLine Advisers sold out of Acutus Medical Inc (AFIB) in Q2 2022, closing a stake of 12,238 shares — an estimated $17K sold.

RhumbLine Advisers first reported a position in AFIB in Q3 2020 and held it in 6 quarters. The position peaked at $283K in Q4 2020. 47 funds tracked by Wall St. Rank hold AFIB as of Q2 2022.

  • RhumbLine Advisers reported no remaining Acutus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 12,238 Acutus Medical Inc shares in Q2 2022, an estimated $17K.
  • RhumbLine Advisers first reported a position in Acutus Medical Inc in Q3 2020 and held it in 6 quarters.
  • RhumbLine Advisers's Acutus Medical Inc position peaked at $283K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.